Regulation of HL-60 differentiation by lipoxygenase pathway metabolites in vitro

Cancer Res. 1990 Nov 15;50(22):7257-60.

Abstract

We have studied the effects of lipoxygenase inhibition and metabolite addition of HL-60 cells induced to differentiate. When HL-60 are induced by dimethyl sulfoxide (DMSO) in the presence of an inhibitor of lipoxygenase, caffeic acid, there is a marked change from the expected phenotype of mature granulocytes to a population composed predominantly of mature monocytes. (DMSO alone: 54% granulocytes, 10% monocytes; DMSO + caffeic acid: 23% granulocytes, 53% monocytes.) Addition of leukotriene D4 to DMSO-induced, caffeic acid-inhibited cultures resulted in a dose-dependent recovery of the granulocyte phenotype. Addition of lipoxygenase inhibitors to phorbol ester-treated HL-60 cells did not alter the expected monocytic differentiation. These results support a role for leukotriene D4 in the regulation of granulocyte differentiation of HL-60 cells induced with DMSO.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Caffeic Acids / pharmacology
  • Cell Adhesion / drug effects
  • Cell Differentiation / drug effects*
  • Dimethyl Sulfoxide / pharmacology
  • Epoprostenol / analogs & derivatives
  • Epoprostenol / pharmacology
  • Granulocytes / cytology
  • Histocytochemistry
  • Humans
  • In Vitro Techniques
  • Lipoxygenase Inhibitors*
  • Monocytes / cytology
  • SRS-A / pharmacology
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tretinoin / pharmacology
  • Tumor Cells, Cultured

Substances

  • Caffeic Acids
  • Lipoxygenase Inhibitors
  • SRS-A
  • Tretinoin
  • Epoprostenol
  • Tetradecanoylphorbol Acetate
  • piriprost
  • caffeic acid
  • Dimethyl Sulfoxide